Delivery Order SPE2DB20D1100-SPE2DB24FB0E6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $9,105.03 firm fixed price delivery order is for 4563605882 - Ondansetron ODT 4 mg Tablet 30s, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,654.62 firm fixed price delivery order is for the supply of Ondansetron ODT 8 mg tablets. The award is not associated with any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,595.64 firm fixed-price delivery order is for 4,564,703,624 units of ondansetron ODT 4 mg tablets. This contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the supply of Ondansetron ODT 4 MG tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,281.99 firm fixed-price delivery order has a completion date of March 6, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $3,372.38 Firm Fixed Price Delivery Order is for the supply of 4,564,944,629 units of the prescription medication Ondansetron ODT 8 mg tablets. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award, with a ceiling value of $14,814.30, is a firm fixed price delivery order contract for the supply of Ondansetron ODT 4 mg tablets. The contract has no set-aside designation. Amerisourcebergen Drug Corp previously received an indefinite delivery contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $13,789.12 Firm Fixed Price delivery order is for the supply of 4564310887 Ondansetron ODT 4 mg Tablets, with a completion date of April 18, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,944.00 firm fixed-price delivery order is for the supply of Ondansetron ODT 8 mg tablets to support military treatment facilities. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a division of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $2,189.62 firm fixed price delivery order is for the supply of Ondansetron ODT 8 mg tablets. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,191.50, is for the delivery of Ondansetron ODT 4 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 18, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FB0E6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $11,630.34 firm fixed price delivery order is for Ondansetron ODT 8 mg tablets (30 count) and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The company also holds a separate indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division worth up to $750,000 for medical supplies and prescription medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 3/29/24 |